V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20130368 | 20087562 | 1.59 | 72.1 | Palliative (P) | 2019-03-14 | 2019-04-04 | ESPAC-4 TRIAL | 01 | N | ESPAC TRIAL | 100564071 |
| 20130428 | 20087563 | 1.79 | 82.9 | null | 2017-07-04 | 2017-07-04 | Panitumumab | 02 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100859039 |
| 20130468 | 20087564 | 1.01 | 51 | 03 | null | 2017-01-18 | Fluorouracil + Folinic + RT Bossett | 1 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101289378 |
| 20130498 | 20087565 | 1.68 | 55 | Palliative (P) | 2017-02-28 | 2017-02-28 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | MITOMYCIN | 100808005 |
| 20130514 | 20087566 | 1.64 | 79.4 | Palliative (P) | 2019-08-03 | 2019-08-17 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | N | N | CISPLATIN + FLUOROURACIL + RT | 101856671 |
| 20130588 | 20087567 | 1.79 | 0.1 | 03 | 2021-10-22 | 2021-10-22 | Hydroxycarbamide | 02 | null | BORTEZOMIB | 101616838 |
| 20130606 | 20087568 | 1.6 | 76 | Palliative (P) | 2017-03-15 | 2017-03-26 | CHOP R - 21 days | N | N | FLUOROURACIL + RT | 101804728 |
| 20130639 | 20087569 | 1.54 | 54.6 | 03 | 2018-08-10 | 2018-08-22 | Carboplatin + Pemetrexed | N | N | ESPAC TRIAL | 100312151 |
| 20130640 | 20087570 | 1.68 | 62.8 | Palliative (P) | 2017-03-25 | 2017-03-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | VDC | 101565384 |
| 20130681 | 20087571 | 1.68 | 90 | null | 2019-12-24 | 2019-12-27 | Hydroxycarbamide | N | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100098582 |
| 20130723 | 20087572 | 1.64 | 62.6 | 03 | 2017-10-23 | 2017-10-29 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | LENALIDOMIDE | 101603228 |
| 20130762 | 20087573 | null | 75 | 03 | 2016-09-01 | 2016-09-15 | ACELARATE Trial | 02 | N | DOCETAXEL | 100789923 |
| 20130831 | 20087574 | 1.7 | 90 | Palliative (P) | 2019-11-23 | 2019-11-23 | PHITT Trial | 02 | N | ECARBOX | 100893410 |
| 20130859 | 20087575 | 1.84 | 68.2 | Adjuvant (A) | 2021-07-31 | 2021-07-31 | CAPE + OXALIPLATIN + TRASTUZUMAB | 01 | N | ARISTOTLE TRIAL | 100969867 |
| 20130958 | 20087576 | 1.6 | 71 | Palliative (P) | 2019-03-31 | 2019-05-05 | Cisplatin + Fluorouracil + RT 5day | N | N | DOXORUBICIN + OLARATUMAB | 101264726 |
| 20130993 | 20087577 | 1.89 | 83.05 | Palliative (P) | null | 2019-02-22 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | null | N | CAPECITABINE + STREPTOZOCIN | 101654102 |
| 20131080 | 20087579 | 1.63 | 59.85 | 03 | 2018-09-18 | 2018-09-23 | ARISTOTLE TRIAL | 02 | N | BALLAD TRIAL | 100853285 |
| 20131277 | 20087581 | 1.65 | 95.15 | Palliative (P) | 2017-04-06 | 2017-04-06 | null | 02 | N | PEMBROLIZUMAB | 100068975 |
| 20131286 | 20087582 | 1.57 | 108 | Palliative (P) | 2019-04-08 | 2019-04-24 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100877009 |
| 20131302 | 20087583 | 1.8 | 84 | null | 2017-07-20 | 2017-08-07 | PHITT E2 PLADO | N | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100231563 |
| 20131500 | 20087584 | 1.72 | 69.4 | 03 | 2019-11-06 | 2019-11-10 | EOF | 02 | N | ARISTOTLE TRIAL | 100071965 |
| 20131657 | 20087587 | 1.8 | 80 | Palliative (P) | 2021-11-06 | 2021-12-10 | FOXTROT TRIAL | N | N | GEMCITABINE + PACLITAXEL | 100573187 |
| 20131694 | 20087588 | 1.69 | 62 | null | null | 2019-11-02 | BCG Intravesical | 02 | N | EOF | 101227084 |
| 20131712 | 20087589 | 1.77 | 95.5 | Palliative (P) | 2020-01-15 | 2020-01-16 | ARISTOTLE TRIAL | 02 | N | CAPECITABINE + LOMUSTINE | 101029175 |
| 20131724 | 20087590 | 1.77 | null | 03 | 2016-07-17 | 2016-07-18 | ESHAP | 02 | N | IRINOTECAN | 100383634 |
| 20131785 | 20087591 | 1.78 | 64.6 | 03 | null | 2020-04-26 | Gemcitabine+Paclitaxel (Neo-tAnGo) | Y | N | CISPLATIN + IFOSFAMIDE + MITOMYCIN | 100686896 |
| 20131833 | 20087592 | 0 | 8.5 | Palliative (P) | 2018-07-03 | 2018-07-15 | TACE-3 TRIAL | 02 | N | EC | 100567027 |
| 20131845 | 20087593 | 1.68 | 73.3 | Adjuvant (A) | 2016-06-09 | 2016-06-13 | Raltitrexed | 02 | N | BENDAMUSTINE + RITUXIMAB | 101408031 |
| 20131904 | 20087595 | 1.68 | 60.7 | Palliative (P) | 2017-07-11 | 2017-07-23 | MITOMYCIN | 02 | N | RITUXIMAB | 100112547 |
| 20131959 | 20087596 | 0 | 20.5 | null | 2019-02-12 | 2019-02-28 | ECarboX | 02 | Y | FOXTROT TRIAL | 101090541 |
| 20131972 | 20087597 | 1.71 | 88.8 | null | 2018-11-17 | 2018-11-24 | Avelumab | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101470225 |
| 20132234 | 20087599 | 0 | 0 | Palliative (P) | 2020-12-15 | 2020-12-22 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | DOCETAXEL | 101554141 |
| 20132255 | 20087600 | 1.57 | 126.1 | 03 | 2017-10-01 | 2017-10-11 | EVEROLIMUS | 02 | N | GEMCITABINE + PACLITAXEL | 101091159 |
| 20132270 | 20087601 | 1.78 | 60 | Palliative (P) | 2017-08-16 | 2017-08-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | NIVOLUMAB | 101458958 |
| 20132361 | 20087602 | 1.82 | null | Palliative (P) | null | 2020-03-07 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | ACELARATE TRIAL | 101338281 |
| 20132504 | 20087604 | 1.73 | 82 | Palliative (P) | 2016-04-19 | 2016-04-19 | null | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101336593 |
| 20132554 | 20087606 | 1.8 | 76.9 | Palliative (P) | 2019-10-16 | 2019-11-03 | ACELARATE Trial | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100882584 |
| 20132589 | 20087607 | 1.59 | 58.8 | Palliative (P) | 2015-10-03 | 2015-10-03 | PLATO Trials | 01 | N | PLATO TRIAL | 101612757 |
| 20132615 | 20087608 | 1.86 | 70.55 | Palliative (P) | 2018-01-20 | 2018-01-21 | CHOP R - 21 days | 02 | N | ECARBOX | 101410148 |
| 20132689 | 20087609 | 0 | 10.9 | Palliative (P) | 2018-01-15 | 2018-01-22 | BCG Intravesical | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100298501 |
| 20132705 | 20087610 | 1.8 | 76.8 | null | 2016-08-25 | 2016-08-25 | CARBOPLATIN + FLUOROURACIL | 02 | N | OXALIPLATIN | 101398472 |
| 20132768 | 20087611 | 1.75 | 103.9 | 03 | 2018-11-16 | 2018-12-12 | REGORAFENIB | null | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 100870828 |
| 20132813 | 20087612 | 1.63 | 37 | Adjuvant (A) | 2020-03-18 | 2020-03-22 | Ralitrexed | 02 | N | OSIMERTINIB | 100838345 |
| 20133011 | 20087613 | null | null | 03 | 2020-12-31 | 2020-12-31 | BCG Intravesical | 02 | null | TIPIRACIL + TRIFLURIDINE | 100230205 |
| 20133069 | 20087616 | 1.61 | 57 | null | 2020-05-21 | 2020-05-27 | CAPECITABINE + LOMUSTINE | 02 | N | NEO-AEGIS TRIAL | 100072128 |
| 20133073 | 20087617 | 1.7 | 64.3 | 03 | null | 2016-04-20 | Sunitinib | 01 | N | EOF | 100460249 |
| 20133103 | 20087618 | 1.69 | 65.65 | Palliative (P) | 2018-07-26 | 2018-08-08 | Capecitabine + Streptozocin | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100144986 |
| 20133150 | 20087619 | 1.83 | 72.25 | Palliative (P) | 2017-05-06 | 2017-06-01 | PEG INTERFERON | 01 | N | ACELARATE TRIAL | 100374246 |
| 20133166 | 20087620 | 1.72 | 83.7 | Palliative (P) | 2019-01-27 | 2019-01-28 | Carboplatin + Docetaxel | 02 | N | GEMCITABINE + PACLITAXEL | 101471080 |
| 20133215 | 20087621 | 1.86 | 93.3 | 03 | null | 2016-01-25 | Melphalan IV High dose | 2 | N | CAPECITABINE + STREPTOZOCIN | 101746605 |